Non-Current Liabilities
Debt - Unamortized Discount (Premium) and Issuance Costs, Net
Medtronic Debt - Unamortized Discount (Premium) and Issuance Costs, Net decreased by 3.3% to $118M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 2.5%, from $121M to $118M. Over 5 years (FY 2020 to FY 2025), Debt - Unamortized Discount (Premium) and Issuance Costs, Net shows relatively stable performance with a -1.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
First reportedQ1 2015
Last reportedQ4 2025Feb 24, 2026
Metric ID:
debt_unamortized_discount_premium_issuance_costsHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $120M | $117M | $113M | $109M | $101M | $116M | $115M | $124M | $120M | $117M | $113M | $110M | $129M | $125M | $121M | $117M | $113M | $122M | $118M |
| QoQ Change | — | -2.5% | -3.4% | -3.5% | -7.3% | +14.9% | -0.9% | +7.8% | -3.2% | -2.5% | -3.4% | -2.7% | +17.3% | -3.1% | -3.2% | -3.3% | -3.4% | +8.0% | -3.3% |
| YoY Change | — | — | — | — | -15.8% | -0.9% | +1.8% | +13.8% | +18.8% | +0.9% | -1.7% | -11.3% | +7.5% | +6.8% | +7.1% | +6.4% | -12.4% | -2.4% | -2.5% |
Range$101M – $129M
CAGR-0.4%
Avg YoY Growth+1.1%
Median YoY Growth+0.9%
Debt - Unamortized Discount (Premium) and Issuance Costs, Net at Other Companies
Frequently Asked Questions
- What is Medtronic's debt - unamortized discount (premium) and issuance costs, net?
- Medtronic (MDT) reported debt - unamortized discount (premium) and issuance costs, net of $118M in Q4 2025.
- How has Medtronic's debt - unamortized discount (premium) and issuance costs, net changed year-over-year?
- Medtronic's debt - unamortized discount (premium) and issuance costs, net decreased by 2.5% year-over-year, from $121M to $118M.
- What is the long-term trend for Medtronic's debt - unamortized discount (premium) and issuance costs, net?
- Over 5 years (2020 to 2025), Medtronic's debt - unamortized discount (premium) and issuance costs, net has grown at a -1.6% compound annual growth rate (CAGR), from $128M to $118M.